Arch Capital (ACGL) Notice: 10,000 Shares from Performance Stock to Be Sold

Rhea-AI Filing Summary

Form 144 notice for Arch Capital Group Ltd (ACGL) shows a proposed sale of 10,000 common shares through Charles Schwab & Co., Inc., with an aggregate market value of $941,464 and the securities exchange listed as NASDAQ. The shares were acquired on 03/04/2025 by performance stock lapse from Arch Capital Group Ltd and were paid as equity compensation. The filing lists 373,220,295 shares outstanding and indicates an approximate sale date of 08/22/2025. The filer certifies they are not aware of any undisclosed material adverse information about the issuer and provides the standard Rule 144 attestation regarding trading plans and Rule 10b5-1.

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice for a small, post-vesting insider sale; no material new information about the issuer.

The filing documents a proposed sale of 10,000 common shares acquired on 03/04/2025 via performance stock lapse and designated as equity compensation. The aggregate market value reported is $941,464 against 373,220,295 shares outstanding. This appears to be a routine disclosure under Rule 144 to enable compliance with resale restrictions rather than a liquidity event intended to signal material company developments. The filer also affirms absence of undisclosed material adverse information consistent with the form's standard attestation.

Corporate Governance Expert

TL;DR: Standard insider reporting and attestation; procedural compliance with no governance red flags disclosed.

The notice identifies Charles Schwab & Co., Inc. as the broker and an approximate sale date of 08/22/2025. The acquisition via performance stock lapse indicates compensation-related vesting rather than open-market purchase. The filing contains the required representation about nonexistence of material nonpublic information and references Rule 10b5-1 planning. There are no disclosures here of related-party transactions, accelerated vesting, or other governance concerns.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	10000	941464.00	373220295	08/22/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/04/2025	Performance Stock Lapse	ARCH CAPITAL GROUP LTD.			10000	03/04/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ACGL Form 144 report disclose?

The form discloses a proposed sale of 10,000 common shares acquired on 03/04/2025 by performance stock lapse, with aggregate market value $941,464 and sale date approx. 08/22/2025.

Who is handling the sale reported on the ACGL Form 144?

The broker listed is Charles Schwab & Co., Inc., 3000 Schwab Way, Westlake TX 76262.

How many ACGL shares are outstanding according to the filing?

The filing reports 373,220,295 shares outstanding.

How were the shares acquired that are being sold under Rule 144?

The shares were acquired on 03/04/2025 via a performance stock lapse from Arch Capital Group Ltd as equity compensation.

Does the filer state any undisclosed material information about ACGL?

The filer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.